Immuneering CFO Andrew Gengos files initial beneficial ownership statement

• Immuneering CFO Andrew Gengos filed an initial Form 3 showing direct ownership of 225,000 shares of Class A common stock as of July 16, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001790340-26-000080), on July 16, 2026, and is solely responsible for the information contained therein.